Genelabs Technologies' Unattributed VC Round

Genelabs Technologies raised a round of funding on May 12, 2003.

is discovering compounds that selectively inhibit replication of the hepatitis C virus, and advancing preclinical development of compounds from this hepatitis C virus drug discovery program, while als…

Articles about Genelabs Technologies' Unattributed VC Round: